These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 31235888)

  • 21. Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection.
    Band VI; Hufnagel DA; Jaggavarapu S; Sherman EX; Wozniak JE; Satola SW; Farley MM; Jacob JT; Burd EM; Weiss DS
    Nat Microbiol; 2019 Oct; 4(10):1627-1635. PubMed ID: 31209306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heteroresistance: A cause of unexplained antibiotic treatment failure?
    Band VI; Weiss DS
    PLoS Pathog; 2019 Jun; 15(6):e1007726. PubMed ID: 31170271
    [No Abstract]   [Full Text] [Related]  

  • 23. Why is antibiotic resistance a deadly emerging disease?
    Courvalin P
    Clin Microbiol Infect; 2016 May; 22(5):405-7. PubMed ID: 26806259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.
    Kester JC; Fortune SM
    Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of Drug Resistance in Bacteria.
    Waclaw B
    Adv Exp Med Biol; 2016; 915():49-67. PubMed ID: 27193537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment.
    Kao CY; Lee AY; Huang AH; Song PY; Yang YJ; Sheu SM; Chang WL; Sheu BS; Wu JJ
    Infect Genet Evol; 2014 Apr; 23():196-202. PubMed ID: 24576534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic control of antibiotic resistance in hospitals: a simulation study.
    Haber M; Levin BR; Kramarz P
    BMC Infect Dis; 2010 Aug; 10():254. PubMed ID: 20738872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions.
    Cox G; Wright GD
    Int J Med Microbiol; 2013 Aug; 303(6-7):287-92. PubMed ID: 23499305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Heteroresistance in
    Stojowska-Swędrzyńska K; Łupkowska A; Kuczyńska-Wiśnik D; Laskowska E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008891
    [No Abstract]   [Full Text] [Related]  

  • 30. Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant
    Band VI; Satola SW; Smith RD; Hufnagel DA; Bower C; Conley AB; Rishishwar L; Dale SE; Hardy DJ; Vargas RL; Dumyati G; Kainer MA; Phipps EC; Pierce R; Wilson LE; Sorensen M; Nilsson E; Jordan IK; Burd EM; Farley MM; Jacob JT; Ernst RK; Weiss DS
    mBio; 2021 Jan; 12(1):. PubMed ID: 33500343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between antibiotic resistance and clinical outcome of anaerobic infections; mini-review.
    Dubreuil L; Veloo AC; Sóki J;
    Anaerobe; 2021 Dec; 72():102463. PubMed ID: 34597797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two types of colistin heteroresistance in
    Hong YK; Kim H; Ko KS
    Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of ciprofloxacin heteroresistance in foodborne Salmonella enterica serovar Agona.
    Zhang CZ; Zhang Y; Ding XM; Lin XL; Lian XL; Trampari E; Thomson NM; Ding HZ; Webber MA; Jiang HX
    J Antimicrob Chemother; 2020 Oct; 75(10):2773-2779. PubMed ID: 32747937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glycopeptide heteroresistance and tolerance in hospital grampositive isolates: "invisible" phenomena to the clinician with clinical implications?].
    Aguilar L; Giménez MJ; Barberán J
    Rev Esp Quimioter; 2009 Dec; 22(4):173-9. PubMed ID: 20082037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications.
    Karakonstantis S; Saridakis I
    Int J Antimicrob Agents; 2020 Aug; 56(2):106065. PubMed ID: 32599229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence and dissemination of antibiotic resistance: a global problem.
    Choudhury R; Panda S; Singh DV
    Indian J Med Microbiol; 2012; 30(4):384-90. PubMed ID: 23183460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic stewardship: a call for action by the urologic community.
    Wagenlehner FM; Bartoletti R; Cek M; Grabe M; Kahlmeter G; Pickard R; Bjerklund-Johansen TE
    Eur Urol; 2013 Sep; 64(3):358-60. PubMed ID: 23746854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heteroresistance at the single-cell level: adapting to antibiotic stress through a population-based strategy and growth-controlled interphenotypic coordination.
    Wang X; Kang Y; Luo C; Zhao T; Liu L; Jiang X; Fu R; An S; Chen J; Jiang N; Ren L; Wang Q; Baillie JK; Gao Z; Yu J
    mBio; 2014 Feb; 5(1):e00942-13. PubMed ID: 24520060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
    Mashaly GE; El-Mahdy RH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing epidemiology of resistance.
    Hawkey PM; Jones AM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.